Adage Capital Partners’s Connect Biopharma Holdings CNTB Stock Holding History

Adage Capital Partners’s Portfolio CNTB Stock Details CNTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-650,000	Closed	-$532K	–	871
2023 Q3	$532K	Hold	650,000	–	–	﹤0.01%	777
2023 Q2	$735K	Sell	650,000 -377,519	-37%	-$423K	﹤0.01%	772
2023 Q1	$1.03M	Hold	1,027,519	–	–	﹤0.01%	795
2022 Q4	$892K	Sell	1,027,519 -250,000	-20%	-$206K	﹤0.01%	843
2022 Q3	$1.65M	Sell	1,277,519 -400,000	-24%	-$481K	﹤0.01%	867
2022 Q2	$1.46M	Buy	1,677,519 +240,019	+17%	+$353K	﹤0.01%	899
2022 Q1	$4.34M	Buy	1,437,500 +187,500	+15%	+$791K	0.01%	844
2021 Q4	$6.44M	Buy	+1,250,000	New	+$13.9M	0.01%	788

Other funds holding CNTB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Adage Capital Partners's CNTB Position: Q4 2023 in Review

Adage Capital Partners sold out of Connect Biopharma Holdings (CNTB) in Q4 2023, closing a stake of 650,000 shares — an estimated $532K sold.

Adage Capital Partners first reported a position in CNTB in Q4 2021 and held it in 8 quarters. The position peaked at $6.44M in Q4 2021. 15 funds tracked by Wall St. Rank hold CNTB as of Q4 2023.

Adage Capital Partners reported no remaining Connect Biopharma Holdings position as of Q4 2023 after selling out during the quarter.
Adage Capital Partners sold 650,000 Connect Biopharma Holdings shares in Q4 2023, an estimated $532K.
Adage Capital Partners first reported a position in Connect Biopharma Holdings in Q4 2021 and held it in 8 quarters.
Adage Capital Partners's Connect Biopharma Holdings position peaked at $6.44M in Q4 2021.
15 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q4 2023.

Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.